Transcept's drug for obsessive compulsive disorder fails trial
(Reuters) - Transcept Pharmaceuticals Inc said a mid-stage trial of its experimental drug for obsessive compulsive disorder did not meet the main goal...
Source: http://goo.gl/mag/RWRZXOQ
No comments:
Post a Comment